TrialsgrambetaRCTs are beautiful

MITRA-FR

2018

Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation

In 304 patients with heart failure and severe secondary mitral regurgitation, transcatheter mitral repair did not reduce death or heart-failure hospitalisation compared with medical therapy alone.

Result

Efficacy: Death or HF hospitalisation at 12 monthsOR 1.16 (95% CI 0.73-1.84) · P = 0.53

Below 1 favours transcatheter mitral repair, above 1 favours medical therapy alone.

Event rates
Absolute difference
3.3 points

The absolute difference is derived from the event rates.

Original publication
Subtopic
Mitral
Design
Open-label RCT, 1 yr
Relevance
Important: one of several pillars.
Source
Obadia JF, et al. N Engl J Med. 2018;379(24):2297-2306.doi 10.1056/NEJMoa1805374

Discussion & critique

Negative where COAPT was positive, explained by patient selection: 'proportionate' MR with larger ventricles. The EROA/LVEDV ratio helps identify who benefits from repair.

Discussed in podcasts